Phase I Trial of a 90-Minute Infusion of the Fusion Toxin DAB486IL-2 in Hematological Cancers

C. F. LeMaistre, Fiona E. Craig, Carole Meneghetti, Becky McMullin, David H. Boldt, James Reuben, Michael Rosenblum, Karen Parker, Thasia Woodworth

Research output: Contribution to journalArticlepeer-review

77 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I Trial of a 90-Minute Infusion of the Fusion Toxin DAB486IL-2 in Hematological Cancers'. Together they form a unique fingerprint.

Medicine & Life Sciences